[
  {
    "date": "2023-09-29",
    "symbol": "EDSA",
    "period": "FY",
    "entityregistrantname": "EDESA BIOTECH, INC.",
    "entitycentralindexkey": 1540159,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--09-30",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "2023-09-30",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2023,
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityfilenumber": "001-37619",
    "entityincorporationstatecountrycode": "Z4",
    "entityaddressaddressline1": "100 Spy Court",
    "entityaddresscityortown": "Markham",
    "entityaddressstateorprovince": "ON",
    "entityaddresscountry": "CA",
    "entityaddresspostalzipcode": "L3R 5H6",
    "cityareacode": 289,
    "icfrauditorattestationflag": "false",
    "auditorname": "MNP LLP",
    "auditorlocation": "Toronto, Canada",
    "auditorfirmid": 1930,
    "localphonenumber": "800-9600",
    "security12btitle": "Common Shares, without par value",
    "tradingsymbol": "EDSA",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 5361397,
    "accountsandotherreceivablesnetcurrent": 626543,
    "prepaidexpenseandotherassetscurrent": 448912,
    "assetscurrent": 6436852,
    "propertyplantandequipmentnet": 8702,
    "depositsassetsnoncurrent": 173490,
    "finitelivedintangibleassetsnet": 2180020,
    "operatingleaserightofuseasset": 91373,
    "assets": 8890437,
    "accountspayableandaccruedliabilitiescurrent": 1747150,
    "operatingleaseliabilitycurrent": 74714,
    "liabilitiescurrent": 1821864,
    "operatingleaseliabilitynoncurrent": 19773,
    "liabilities": 1841637,
    "capitalunits": 46643151,
    "additionalpaidincapital": 13039265,
    "accumulatedothercomprehensiveincomelossnetoftax": -214648,
    "retainedearningsaccumulateddeficit": -52418968,
    "stockholdersequity": 7048800,
    "liabilitiesandstockholdersequity": 8890437,
    "commonstocksharesissued": 3075473,
    "commonstocksharesoutstanding": 2380280,
    "researchanddevelopmentexpense": 4794549,
    "generalandadministrativeexpense": 4428209,
    "operatingincomeloss": -9222758,
    "reimbursementgrantincome": 581039,
    "interestincomeother": 289846,
    "foreigncurrencytransactiongainlossbeforetax": -21742,
    "nonoperatingincomeexpense": 849143,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -8373615,
    "incometaxexpensebenefit": 800,
    "netincomeloss": -8374415,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -1046,
    "comprehensiveincomenetoftax": -8375461,
    "weightedaveragenumberofcommonsharesoutstanding": 2858929,
    "earningpersharebasicanddiluted": -2.93,
    "profitloss": 8374415,
    "depreciationandamortization": 183471,
    "sharebasedcompensation": 1246457,
    "increasedecreaseinaccountsandotherreceivables": -562770,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -301504,
    "increasedecreaseinaccountspayableandaccruedliabilities": -556270,
    "netcashprovidedbyusedinoperatingactivities": -6636483,
    "proceedsfromissuanceofcommonstock": 4345017,
    "proceedsfromwarrantexercises": 770532,
    "paymentsofstockissuancecosts": 285438,
    "netcashprovidedbyusedinfinancingactivities": 4830111,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": 76850,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -1729522,
    "sharesissued": 3075473,
    "issuanceofcommonsharesandwarrantsinequityofferingshares": 580876,
    "issuanceofcommonsharesandwarrantsinequityofferingamount": 3400191,
    "issuanceofcommonsharesuponexerciseofwarrantsshares": 100760,
    "issuanceofcommonsharesuponexerciseofwarrantsamount": 994618,
    "issuanceofcommonsharesuponexerciseofrestrictedstockunitsshares": 13557,
    "issuanceofcommonsharesuponexerciseofrestrictedstockunitsamount": 75920,
    "issuancecostsamount": 300677,
    "cumulativeearningsdeficit": -52400000,
    "workingcapital": 4600000,
    "cashandcashequivalentsatcarryingvalue": 5400000,
    "shelfregistrationstatement": "In August 2022 the Company filed a $150.0 million shelf registration statement, under which the Company entered into an equity distribution agreement with Canaccord for $20.0 million in gross proceeds, subject to certain offering limitations that currently allows the Company to offer and sell common shares having an aggregate gross sales price of up to $8.4 million (Canaccord ATM). There was approximately $7.1 million of available capacity on the Canaccord ATM as of September 30, 2023.",
    "netcashusedinoperatingactivities": 6600000,
    "netlosses": -8400000,
    "lineofcreditfacilitymaximumborrowingcapacity": 3500000,
    "saleofstocknumberofsharesissuedintransaction": 196401,
    "proceedsfromsaleofcommonstock": 2600000,
    "aggregategrosssalespriceofcommonshare": 1300000,
    "operatingleaseswithterms": "P12M",
    "fixedassetsdepreciation": 0.3,
    "propertyplantandequipmentusefullifes": "P3Y",
    "propertyplantandequipmentgross": 46945,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 43846,
    "depreciation": 4328000000,
    "finitelivedintangibleassetsgross": 2529483,
    "finitelivedintangibleassetsaccumulatedamortization": -349463,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 101172,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 101172,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 101172,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 101172,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 101172,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 1674160,
    "finitelivedintangibleassetsamortizationfutureexpense": 2180020,
    "amortizationofintangibleassets": 1011720000,
    "finitelivedintangibleassetusefullifes": "P25Y",
    "capitalleasesindemnificationagreementsdescriptions": "The required upfront license payment of $2.5 million was paid by issuance of Series A-1 Convertible Preferred Shares",
    "operatingleasecost": 82358,
    "remainingleasetermmonths": "P15Y",
    "operatingleaseweightedaveragediscountratepercent": 0.092,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 79697,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 19924,
    "lesseeoperatingleaseliabilitypaymentsdue": 99621,
    "imputedinterest": 5134,
    "operatingleaseliability": 94487,
    "operatingleasepaymentsuse": 79222,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 1,
    "descriptionofaqquiredrugs": "the Company acquired drug substance of one of the Constructs for an aggregate purchase price of $5.0 million. The Company recorded an expense of $2.5 million for the second installment payment during the year ended September 30, 2022. No expense was recorded during the year ended September 30, 2023",
    "remainingpaymentsofcontingent": 356000000,
    "paymentstoacquireinvestments": 18400000,
    "paymentsforrestructuring": 40000000,
    "classofwarrantorrightoutstanding": 720909,
    "numberofwarrantsissued": 384496,
    "numberofwarrantsexercised": -100760,
    "numberofwarrantsexpired": -84545,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 19.51,
    "weightedaverageexercisepricewarrantsissued": 8.75,
    "weightedaverageexercisepricewarrantsexercised": 7.65,
    "weightedaverageexercisepricewarrantsexpired": 37.29,
    "warrantexpirationdate": "December 2023",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P3Y1M20D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9073,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 420615,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 118579,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeitedinperiod": -12779,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 25.6,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 7.47,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeitedinperiodweightedaverageexerciseprice": 22.76,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 1973.2,
    "weightedaveragegrantdatefairvaluebeginningbalance": 23.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageforfeiteddatefairvalue": 5.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeitedinperiodweightedaverageforfeiteddatefairvalue": 16.23,
    "weightedaveragegrantdatefairvalueexpired": 1973.2,
    "weightedaveragegrantdatefairvalueendingbalance": 18.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 497,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationdates": "Dec 2023",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0362,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0418,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.953,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.9734,
    "numberofrestrictedstockunitconvertedtocommonshares": -13557,
    "weightedaveragegrantdatefairvalueconvertedtocommonshares": 5.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardrsuoutstandingnumber": 33045,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P85M",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P35M",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensation": 12000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 130960,
    "expectedterm": "P10M",
    "grantdate": "P5M",
    "aggregategrosssalesprice": 1300000,
    "stockissuedduringperiodsharesother": 196401,
    "expectedoptionforfeituresterm": "P111Y",
    "numberofsharesavailableforissuance": 575737,
    "optionterm": "P10Y",
    "remainingnumberofoptionsavailableforgrant": 81765,
    "otherincome": 600000,
    "agreementexpirationdescription": "The Agreement will expire on the later of December 31, 2042 or the date of the last repayment, unless earlier terminated, subject to certain provisions that extend three (3) years beyond the term or early termination of the Agreement",
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterests": -8374000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.265,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -2219000,
    "incometaxreconciliationforeignincometaxratedifferential": -207200,
    "incometaxreconciliationnondeductibleexpense": 339000,
    "deferredtaxassetsotherlosses": 899000,
    "incometaxreconciliationotherreconcilingitems": -94000,
    "incometaxreconciliationotheradjustments": -89000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 1372000,
    "deferredtaxassetstaxcreditcarryforwardsforeign": 13943000,
    "deferredtaxassetsotherlosscarryforwards": 731000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1371000,
    "deferredtaxassetstaxdeferredexpense": 585000,
    "deferredtaxassetsoperatingleaseliabilities": 25000,
    "deferredtaxassetsother": 43000,
    "deferredtaxassetsgross": 16699000,
    "deferredtaxassetsvaluationallowance": 16466000,
    "deferredtaxassetsnet": 233000,
    "deferredtaxliabilitiespropertyplantandequipment": 3000,
    "deferredtaxliabilitiesoperatingleaserightofuseasset": -24000,
    "deferredincometaxesandothertaxreceivablecurrent": 153000,
    "deferredtaxliabilitiesdeferredexpense": 53000,
    "deferredtaxliabilities": 233000,
    "operatinglosscarryforwards": 21000,
    "usnoncapitallossescarriedforward": 3400000,
    "theusstateresearchanddevelopmenttaxcreditscarriedforward": 600000,
    "creditstotaling": 600000,
    "taxlossestotalingfutureincome": 29600000,
    "currencyexchangeratedescription": "Based on the exposure at September 30, 2023, a 10% annual change in the Canadian/U.S. exchange rate would impact the Company’s loss and other comprehensive loss by approximately $0.2 million",
    "currencyexchangerate": 1.3581,
    "relatedpartytransactionexpensefromtransactionswithrelatedparty": 82000,
    "accruedroyaltiescurrent": 15000,
    "commonsharesissued": 89241,
    "proceedsfromissuanceorsaleofequity": 300000
  },
  {
    "date": "2022-09-29",
    "symbol": "EDSA",
    "period": "FY",
    "entityregistrantname": "EDESA BIOTECH, INC",
    "entitycentralindexkey": 1540159,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--09-30",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "2022-09-30",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-37619",
    "entityincorporationstatecountrycode": "Z4",
    "entityaddressaddressline1": "100 Spy Court",
    "entityaddresscityortown": "Markham",
    "entityaddressstateorprovince": "ON",
    "entityaddresscountry": "CA",
    "entityaddresspostalzipcode": "L3R 5H6",
    "cityareacode": 289,
    "localphonenumber": "800-9600",
    "security12btitle": "Common Shares, without par value",
    "tradingsymbol": "EDSA",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "auditorname": "MNP LLP",
    "auditorlocation": "Toronto, Canada",
    "auditorfirmid": 1930,
    "cashandcashequivalentsatcarryingvalue": 7090919,
    "accountsandotherreceivablesnetcurrent": 1255451,
    "prepaidexpenseandotherassetscurrent": 745543,
    "assetscurrent": 9091913,
    "propertyplantandequipmentnet": 12694,
    "depositsassets": 171464,
    "otherintangibleassetsnet": 2281192,
    "operatingleaserightofuseasset": 18465,
    "assets": 11575728,
    "accountspayableandaccruedliabilitiescurrent": 2121802,
    "operatingleaseliabilitycurrent": 18975,
    "liabilitiescurrent": 2140777,
    "longtermloanspayable": 43662,
    "liabilities": 2184439,
    "capitalunits": 42473099,
    "additionalpaidincapital": 11176345,
    "accumulatedothercomprehensiveincomelossnetoftax": -213602,
    "retainedearningsaccumulateddeficit": -44044553,
    "stockholdersequity": 9391289,
    "liabilitiesandstockholdersequity": 11575728,
    "commonstocksharesissued": 16662014,
    "commonstocksharesoutstanding": 16662014,
    "researchanddevelopmentexpense": 13335334,
    "generalandadministrativeexpense": 5035456,
    "operatingincomeloss": -18370790,
    "reimbursementgrantincome": 780257,
    "interestincomeother": 63523,
    "foreigncurrencytransactiongainlossbeforetax": -21114,
    "othernoncashincomeexpense": 822666,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -17548124,
    "incometaxexpensebenefit": 800,
    "netincomeloss": -17548924,
    "goodwillforeigncurrencytranslationgainloss": -8340,
    "comprehensiveincomenetoftax": -17557264,
    "weightedaveragenumberofcommonshares": 16662014,
    "earningpersharebasicanddiluted": -1.05,
    "profitloss": 17548924,
    "depreciationandamortization": 118188,
    "sharebasedcompensation": 2260634,
    "increasedecreaseinaccountsreceivable": 2027454,
    "increasedecreaseinprepaidexpense": 19497,
    "increasedecreaseinaccountspayableandaccruedliabilities": 882843,
    "netcashprovidedbyusedinoperatingactivities": -12279302,
    "paymentstoacquirepropertyplantandequipment": 5656,
    "netcashprovidedbyusedininvestingactivities": -5656,
    "proceedsfromissuanceofcommonsharesandwarrants": 11957687,
    "paymentsofstockissuancecosts": 328059,
    "netcashprovidedbyusedinfinancingactivities": 11629628,
    "effectofexchangeratechangesoncashandcashequivalents": -93010,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -748340,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 7090919,
    "issuancecostswithheldfromgrossproceedsfromissuanceofcommonsharesandwarrants": 393461,
    "fairvalueadjustmentofwarrants": 408059,
    "sharesissued": 16662014,
    "issuanceofcommonsharesandwarrantsinequityofferingshares": 2166884,
    "issuanceofcommonsharesandwarrantsinequityofferingamount": 6239181,
    "othercomprehensiveincomelossnetoftax": -8340,
    "issuancecostsincludingfairvalueofplacementagentwarrants": -863227,
    "issuanceofcommonsharesuponexerciseofprefundedwarrantsshares": 1199727,
    "issuanceofcommonsharesuponexerciseofprefundedwarrantsamount": 2209424,
    "operatingleaseleaseincome": 780000,
    "netloss": 17550000,
    "otherresearchanddevelopmentexpense": 14050000,
    "cashequivalentsatcarryingvalue": 7090000,
    "workingcapital": 6950000,
    "shareholdersequity": 9390000,
    "accumulateddeficit": 44040000,
    "commonsharesinpublicofferingsshares": 1540000,
    "numberofwarrantsissued": 1199727,
    "warrantstopurchasecommonstock": 2739727,
    "proceedsfromotherdebt": 9010000,
    "netcashproceeds": 26200,
    "commonsharessold": 626884,
    "operatingleaseswithterms": "P12Y",
    "fixedassetsdepreciation": 0.3,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentgross": 46674,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 39518,
    "depreciation": 6991000000,
    "finitelivedintangibleassetsgross": 2529483,
    "finitelivedintangibleassetsaccumulatedamortization": 248291,
    "finitelivedintangibleassetsnet": 2281192,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 101172,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 101172,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 101172,
    "finitelivedintangibleassetsamortizationexpenseyearsix": 101172,
    "finitelivedintangibleassetsamortizationexpenseyearseven": 101172,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 1775332,
    "total": 2281192,
    "amortizationofintangibleassets": 1011720000,
    "finitelivedintangibleassetusefullife": "P25Y",
    "capitalleasesindemnificationagreementsdescriptions": "The required upfront license payment of $2.5 million was paid by issuance of Series A-1 Convertible Preferred Shares",
    "operatingleaseliability": 18975,
    "operatingleasecost": 80375,
    "remainingleasetermmonths": "P3Y",
    "operatingleaseweightedaveragediscountratepercent": 0.065,
    "totaloperatingleasesfutureminimumpaymentsduecurrent": 19181,
    "totaloperatingleasesfutureminimumpaymentsdue": 19181,
    "imputedinterest": 206,
    "presentvalueofleaseliabilitiesincludedincurrentliabilities": 18975,
    "operatingleasepaymentsuse": 80377,
    "lesseeoperatingleasedescription": "six-year term through December 2022, with options to renew for another two-year term.",
    "contractualobligationdueinthirdyear": 2612000000000,
    "contractualobligationdueinfourthyear": 386000000000,
    "contractualobligationdueinfifthyear": 50000000000,
    "contractualobligationdueinsixthyear": 37000000000,
    "contractualobligationdueinseventhyear": 49000000000,
    "contractualobligation": 3134000000000,
    "definedbenefitplancontributionsbyemployer": 19740000000,
    "saleofstockpercentageofownershipaftertransaction": 0.03,
    "remainingpaymentsofcontingent": 356000000,
    "costsandexpenses": 2500000,
    "descriptionofacquireddrugs": "the Company acquired drug substance of one of the Constructs for an aggregate purchase price of $5.0 million. Payments of $2.5 million were made for the drug substance during each of the years ended September 30, 2022 and 2021 and included in research and development expenses",
    "paymentstoacquireinvestments": 69100000,
    "licenseexpenses": 25693,
    "paymentsforrestructuring": 18400000,
    "classofwarrantorrightoutstanding": 109375,
    "numberofwarrantsexercised": -1199727,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 8,
    "weightedaverageexercisepricewarrantsissued": 3.59,
    "weightedaverageexercisepriceendingbalance": 4,
    "warrantexpirationdate": "May 2023",
    "fairvalueassumptionriskfreeinterestrate": 0.0237,
    "fairvalueassumptionsexpectedlifeyears": "P5Y6M",
    "fairvalueassumptionsexpectedsharepricevolatility": 0.8709,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2203699,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 500083,
    "numberofoptionsforfeited": -26954,
    "numberofoptionsexpired": -45649,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 4.66,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.66,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 6.56,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 8.05,
    "weightedaveragegrantdatefairvaluebeginningbalance": 37900,
    "weightedaveragegrantdatefairvaluegranted": 24800,
    "weightedaveragegrantdatefairvalueforfeited": 49700,
    "weightedaveragegrantdatefairvalueexpired": 64800,
    "weightedaveragegrantdatefairvalueendingbalance": 34200,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 238,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationdates": "Dec 2022",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0171,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0254,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.8591,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.8659,
    "weightedaveragecontractualliferemainingonoutstandingoptions": "P50Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 1040000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P90Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P96Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 415083,
    "shareprice": 4.93,
    "expectedterm": "P10Y",
    "options": 815265,
    "warrantexpirydate": "2026-02-26",
    "proceedsfromissuanceinitialpublicoffering": 8890000,
    "fairvalueofassetsacquired": 410000,
    "commonsharesinpublicofferingspricepershare": 6.4,
    "expectedoptionforfeituresterm": "P10Y",
    "optionsgrantedexpectedlife": "P5Y",
    "numberofsharesavailableforissuance": 2625951,
    "optionterm": "P10Y",
    "remainingnumberofoptionsavailableforgrant": 422252,
    "otherreceivables": 1100000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterests": -17548000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.265,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -4650000,
    "incometaxreconciliationnondeductibleexpense": 650000,
    "incometaxreconciliationforeignincometaxratedifferential": 976800,
    "incometaxreconciliationotheradjustments": -449000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 3473000,
    "deferredtaxassetstaxcreditcarryforwardsforeign": 11740000,
    "deferredtaxassetsotherlosscarryforwards": 1631000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1052000,
    "deferredtaxassetstaxdeferredexpense": 686000,
    "deferredtaxassetsoperatingleaseliabilities": 5000,
    "deferredtaxassetsother": 15000,
    "deferredtaxassetsgross": 15129000,
    "deferredtaxassetsvaluationallowance": 15093000,
    "deferredtaxassetsnet": 36000,
    "deferredtaxliabilitiespropertyplantandequipment": 15000,
    "deferredtaxliabilitiesoperatingleaserightofuseasset": 5000,
    "deferredtaxliabilitiesdeferredexpense": 16000,
    "deferredtaxliabilities": 36000,
    "operatinglosscarryforwards": 21000,
    "usnoncapitallossescarriedforward": 7666000,
    "theusstateresearchanddevelopmenttaxcreditscarriedforward": 619000,
    "creditstotaling": 600000,
    "taxlossestotalingfutureincome": 25600000,
    "currencyexchangeratedescription": "Based on the exposure at September 30, 2022, a 10% annual change in the Canadian/U.S. exchange rate would impact the Company’s loss and other comprehensive loss by approximately $501,000",
    "currencyexchangerate": 1.3742,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 81000,
    "accruedroyaltiescurrent": 22000
  },
  {
    "date": "2021-09-29",
    "symbol": "EDSA",
    "period": "FY",
    "entityregistrantname": "EDESA BIOTECH, INC.",
    "entitycentralindexkey": 1540159,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "2021-09-30",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2021,
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-37619",
    "entityincorporationstatecountrycode": "Z4",
    "entityaddressaddressline1": "100 Spy Court",
    "entityaddressaddressline2": "Markham",
    "entityaddresscityortown": "ON",
    "entityaddresscountry": "CA",
    "entityaddresspostalzipcode": "L3R 5H6",
    "cityareacode": 289,
    "localphonenumber": "800-9600",
    "security12btitle": "Common Shares, without par value",
    "tradingsymbol": "EDSA",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "researchanddevelopmentexpense": 17947072,
    "generalandadministrativeexpense": 5734260,
    "expensesnet": 23681332,
    "operatingincomeloss": -23681332,
    "reimbursementgrantincome": 10340839,
    "interestincomeother": 11165,
    "foreigncurrencytransactionlossbeforetax": 13022,
    "nonoperatingincomeexpense": 10338982,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -13342350,
    "incometaxexpensebenefit": 800,
    "netincomeloss": -13342350,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 81942,
    "comprehensiveincomenetoftax": -13261208,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 12077822,
    "earningspersharebasicanddiluted": -1.1,
    "depreciationandamortization": 118788,
    "sharebasedcompensation": 3195469,
    "increasedecreaseinaccountsreceivable": -3229954,
    "increasedecreaseinprepaidexpense": -281361,
    "increasedecreaseinaccountspayableandaccruedliabilities": -124724,
    "netcashprovidedbyusedinoperatingactivities": -13664932,
    "paymentstoacquirepropertyplantandequipment": 6146,
    "netcashprovidedbyusedininvestingactivities": -6146,
    "proceedsfromissuanceorsaleofequity": 12662357,
    "proceedsfromwarrantexercises": 1658769,
    "proceedsfromstockoptionsexercised": 41981,
    "paymentsofstockissuancecosts": 188366,
    "netcashprovidedbyusedinfinancingactivities": 14174741,
    "effectofexchangerateoncashandcashequivalents": 121901,
    "cashandcashequivalentsperiodincreasedecrease": 625564,
    "conversionofstockamountconverted1": 2496480,
    "issuancecostswithheldfromproceedsfromissuanceofshares": 1087184,
    "fairvalueofcompensationwarrantstounderwriter": 407022,
    "stockissuedduringperiodsharesnewissues": 2148963,
    "stockissuedduringperiodvaluenewissues": 13749541,
    "issuancecostsincludingfairvalueofunderwriterwarrantsamount": -1841413,
    "stockissuedduringperiodshareswarrantsexercised": 381650,
    "stockissuedduringperiodvaluewarrantsexercised": 1912725,
    "stockissuedduringperiodsharesother": 19746,
    "stockissuedduringperiodvalueother": 69535,
    "preferredreturnonconvertiblepreferredsharesamount": -19525,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationandexerciseofstockoptions": 3195469,
    "conversionofconvertiblepreferredsharesshares": 1129925,
    "conversionofconvertiblepreferredsharesamount": 2496480,
    "operatingleaseleaseincome": 10340000,
    "netloss": 13340000,
    "otherresearchanddevelopmentexpense": 11000000,
    "commonsharesinpublicofferingsshares": 1562500,
    "commonsharesinpublicofferingsvalue": 8890000,
    "issuanceofcommonsharesuponexerciseofwarrants": 987859,
    "netcashproceeds": 5120000,
    "depreciation": 8323000000,
    "deferredsalesinducementsamortizationexpense": 101172,
    "capitalleasesindemnificationagreementsdescription": "The required upfront license payment of $2.5 million was paid by issuance of Series A-1 Convertible Preferred Shares",
    "operatingleasecost": 81207000000,
    "remainingleasetermmonths": "P15Y",
    "operatingleasepaymentsuse": 81209000000,
    "definedbenefitplancontributionsbyemployer": 23786000000,
    "saleofstockpercentageofownershipaftertransaction": 0.03,
    "remainingpaymentsofcontingent": 356000000,
    "costsandexpenses": 2500000,
    "descriptionofacquireddrugs": "the Company acquired drug substance of one of the Constructs for an aggregate purchase price of $5.0 million, payable in two future installments, the first when the Company is ready to initiate a Phase 2 trial and the second when the Company is ready to initiate a Phase 3 trial. A payment of $2.5 million was made for the drug substance during the year ended September 30, 2021",
    "paymentstoacquireinvestments": 69100000,
    "licenseexpenses": 212000,
    "paymentsforrestructuring": 18600000,
    "dividendspreferredstockcash": 19525,
    "conversionofstocksharesissued1": -250,
    "conversionofstockamountissued1": 2496480,
    "shorttermdebtinterestrateincrease": 0.03,
    "numberofwarrantsissued": 109375,
    "numberofwarrantsexercised": -381650,
    "weightedaverageexercisepricewarrantsissued": 8,
    "weightedaverageexercisepricewarrantsexercised": 4.35,
    "warrantexpirationdate": "May 2023",
    "fairvalueassumptionriskfreeinterestrate": 0.0067,
    "fairvalueassumptionsexpectedlifeyears": "P5Y",
    "fairvalueassumptionsexpectedsharepricevolatility": 0.942,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1145000,
    "numberofoptionsexercised": -19746,
    "numberofoptionsforfeited": -22566,
    "numberofoptionsexpired": -1906,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 6.21,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.1,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 6.02,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 102.49,
    "weightedaveragegrantdatefairvaluebeginningbalance": 2560000,
    "weightedaveragegrantdatefairvaluegranted": 4650000,
    "weightedaveragegrantdatefairvalueexercised": 1350000,
    "weightedaveragegrantdatefairvalueforfeited": 4020000,
    "weightedaveragegrantdatefairvalueexpired": 101120000,
    "weightedaveragegrantdatefairvalueendingbalance": 3790000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationdates": "Nov 2021",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0031,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8533,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P103Y",
    "aggregateintrinsicvalues": 4460000,
    "aggregateintrinsicvaluesoptionsexercised": 90000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P36Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 112000,
    "expectedterm": "P10Y",
    "proceedsfromissuanceofcommonstock": 1106625,
    "grantdate": "P36Y",
    "classapurchasewarrantstopurchasecommonshares": 1016036,
    "proceedsfromissuanceinitialpublicoffering": 10000000000000,
    "warrantstopurchasecommonshares": 109375,
    "classapurchasewarrantstopurchasecommonsharesamount": 1008743,
    "classbpurchasewarrantstopurchasecommonsharesamount": 281399,
    "recoveryofdirectcosts": 468699,
    "offsetgrossproceeds": 330025,
    "classbpurchasewarrantstopurchasecommonshares": 677358,
    "proceedsfromissuancemarketinitialpublicoffering": 15000000,
    "underwrittencommonshares": 586463,
    "warrantexpirydate": "2026-02-26",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.265,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -3536000,
    "incometaxreconciliationnondeductibleexpense": 847000,
    "incometaxreconciliationforeignincometaxratedifferential": -309200,
    "incometaxreconciliationotheradjustments": -447000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 3446000,
    "creditstotaling": 600000,
    "taxlossestotalingfutureincome": 25600000,
    "othercomprehensiveincomelosstax": 773000,
    "currencyexchangerate": 1.2711,
    "currencyexchangeratedescription": "Based on the exposure at September 30, 2021, a 10% annual change in the Canadian/U.S. exchange rate would impact the Company’s loss and other comprehensive loss by approximately $773,000",
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 81000
  },
  {
    "date": "2020-09-29",
    "symbol": "EDSA",
    "period": "FY",
    "entityregistrantname": "Edesa Biotech, Inc.",
    "entitycentralindexkey": 1540159,
    "documenttype": "10-K",
    "documentperiodenddate": "2020-09-30",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--09-30",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "A1",
    "entityfilenumber": "001-37619",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2020,
    "cashandcashequivalentsatcarryingvalue": 7213695,
    "receivablesnetcurrent": 87446,
    "prepaidexpenseandotherassetscurrent": 802877,
    "assetscurrent": 8104018,
    "propertyplantandequipmentnet": 14815,
    "finitelivedintangibleassetsnet": 2483536,
    "operatingleaserightofuseasset": 160006,
    "assets": 10762375,
    "accountspayableandaccruedliabilitiescurrent": 1460127,
    "operatingleaseliabilitycurrent": 69730,
    "liabilitiescurrent": 1529857,
    "accountspayableandaccruedliabilitiesnoncurrent": 29928,
    "operatingleaseliabilitynoncurrent": 94460,
    "liabilities": 1654245,
    "preferredstockvalue": 2476955,
    "commonstockvalue": 18500853,
    "additionalpaidincapital": 1550480,
    "accumulatedothercomprehensiveincomelossnetoftax": -287204,
    "retainedearningsaccumulateddeficit": -13132954,
    "stockholdersequity": -13132954,
    "liabilitiesandstockholdersequity": 10762375,
    "commonstocksharesauthorizedunlimited": "Unlimited",
    "commonstocksharesissued": 9615119,
    "commonstocksharesoutstanding": 9615119,
    "revenues": 328801,
    "costofrevenue": 17601,
    "researchanddevelopmentexpense": 3329451,
    "generalandadministrativeexpense": 3382591,
    "operatingexpenses": 6729643,
    "operatingincomeloss": -6400842,
    "investmentincomeinterest": 37778,
    "foreigncurrencytransactiongainlossbeforetax": -366,
    "nonoperatingincomeexpense": 37412,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -6363430,
    "incometaxexpensebenefit": 800,
    "netincomeloss": -6364230,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": 54870,
    "comprehensiveincomenetoftax": -6364230,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 8607161,
    "earningspersharebasicanddiluted": -0.74,
    "depreciationandamortization": 57563,
    "sharebasedcompensation": 598359,
    "increasedecreaseinaccountsreceivable": -127131,
    "increasedecreaseinprepaidexpense": 404066,
    "increasedecreaseinaccountspayableandaccruedliabilities": 998903,
    "netcashprovidedbyusedinoperatingactivities": -4986340,
    "proceedsfromsaleofpropertyplantandequipment": 53412,
    "paymentstoacquirepropertyplantandequipment": 4856,
    "paymentstoacquireintangibleassets": 29483,
    "paymentstoacquiretradingsecuritiesheldforinvestment": 500000,
    "proceedsfromsalematurityandcollectionofshortterminvestments": 500000,
    "netcashprovidedbyusedininvestingactivities": 19073,
    "proceedsfromissuanceofcommonstock": 4360500,
    "proceedsfromwarrantexercises": 3223804,
    "proceedsfromstockoptionsexercised": 11571,
    "paymentsofstockissuancecosts": 475720,
    "paymentsofpreferredstockissuancecosts": 57154,
    "proceedsfrombankdebt": 29748,
    "netcashprovidedbyusedinfinancingactivities": 7092749,
    "effectofexchangerateoncashandcashequivalents": 57630,
    "cashandcashequivalentsperiodincreasedecrease": 2183112,
    "stockissuedduringperiodvalueissuedforlicense": 2500000,
    "shareissuancecostsforcompensationwarrants": 18051,
    "sharesissued": 9615119,
    "stockissuedduringperiodsharesnewissues": 1354691,
    "stockissuedduringperiodvaluenewissues": 1290142,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 125964,
    "stockissuedduringperiodshareswarrantsexercised": 751510,
    "stockissuedduringperiodvaluewarrantsexercised": -530461,
    "stockissuedduringperiodsharesstockoptionsexercised": 4450,
    "stockissuedduringperiodvaluestockoptionsexercised": -9364,
    "dividendspreferredstockcash": 34109,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationandexerciseofstockoptions": 598359,
    "assetsnet": 6570000,
    "propertyplantandequipmentgross": 40345,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 25530,
    "depreciation": 9602,
    "finitelivedintangibleassetsgross": 2529483,
    "finitelivedintangibleassetsaccumulatedamortization": 45947,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 101172,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 101172,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 101172,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 101172,
    "finitelivedintangibleassetsamortizationexpenseyearfive": 101172,
    "finitelivedintangibleassetsamortizationexpenseafteryearfive": 1977676,
    "amortizationofintangibleassets": 45947,
    "operatingleaseliability": 164190,
    "operatingleasecost": 76331,
    "operatingleaseweightedaverageremainingleaseterm1": "P27M",
    "operatingleaseweightedaveragediscountratepercent": 0.065,
    "operatingleasesfutureminimumpaymentsduecurrent": 78362,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 78884,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 19721,
    "operatingleasesfutureminimumpaymentsdue": 176967,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 12777,
    "operatingleasepaymentsuse": 76333,
    "operatingleasesrentexpensenet": 201421,
    "contractualobligationdueinnexttwelvemonths": 4838000,
    "contractualobligationdueinsecondyear": 2572000,
    "contractualobligationdueinthirdyear": 27000,
    "contractualobligationdueinfourthyear": 24000,
    "contractualobligation": 7461000,
    "definedbenefitplancontributionsbyemployer": 11936,
    "convertiblepreferredstocksharesissued": 250,
    "temporaryequity": 2476955,
    "convertiblepreferredstockissuedduringperiodsharesnewissues": 250,
    "convertiblepreferredstockissuedduringperiodvaluenewissues": 2500000,
    "convertiblepreferredstockissuedduringperiodvalueforissuancecosts": -57154,
    "classofwarrantorrightoutstanding": 11778,
    "numberofwarrantsissued": 1705758,
    "numberofwarrantsexercised": -761951,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 3.2,
    "weightedaverageexercisepricewarrantsissued": 4.47,
    "weightedaverageexercisepricewarrantsexercised": 4.31,
    "warrantexpirationdate": "January 2025",
    "fairvalueassumptionriskfreeinterestrate": 0.0155,
    "fairvalueassumptionsexpectedlifeyears": "P9M29D",
    "fairvalueassumptionsexpectedsharepricevolatility": 1.3415,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratewarrants": 0.0161,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1warrants": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratewarrants": 1.0189,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 14000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 366365,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiod": 4450,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 5790,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 333,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 93.24,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.35,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.6,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 2.73,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 145.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 161788,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationdates": "Sep 2030",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0145,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.0414,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P27M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 1148697,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P99M",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 346000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P37M",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.265,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -1686000,
    "incometaxreconciliationnondeductibleexpense": 159000,
    "incometaxreconciliationforeignincometaxratedifferential": 23800,
    "incometaxreconciliationotheradjustments": -144000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 1648000,
    "deferredtaxassetstaxcreditcarryforwardsforeign": 4881000,
    "deferredtaxassetsotherlosscarryforwards": 1609000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1253000,
    "deferredtaxassetstaxdeferredexpense": 473000,
    "deferredtaxassetsoperatingleaseliabilities": 43000,
    "deferredtaxassetsother": 16000,
    "deferredtaxassetsgross": 8275000,
    "deferredtaxassetsvaluationallowance": 8173000,
    "deferredtaxassetsnet": 102000,
    "deferredtaxliabilitiespropertyplantandequipment": 17000,
    "deferredtaxliabilitiesoperatingleaserightofuseasset": 42000,
    "deferredtaxliabilitiesdeferredexpense": 43000,
    "deferredtaxliabilities": 102000,
    "operatinglosscarryforwards": 220000,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 76331,
    "businesscombinationconsiderationtransferredequityinterestsissuedandissuable": 4633499,
    "businesscombinationconsiderationtransferredother1": 61902,
    "businesscombinationconsiderationtransferred1": 4695401,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcashandequivalents": 6389322,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentassetsother": 418837,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumednoncurrentassets": 42045,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentliabilitiesaccountspayable": 1187124,
    "businesscombinationrecognizedidentifiableassetsacquiredandliabilitiesassumedcurrentliabilitiesother": 967679
  },
  {
    "date": "2018-09-29",
    "symbol": "EDSA",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2018-09-30",
    "documentfiscalyearfocus": 2018,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Stellar Biotechnologies, Inc. ",
    "entitycentralindexkey": 1540159,
    "currentfiscalyearenddate": "--09-30",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "tradingsymbol": "SBOT",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "true",
    "entitysmallbusiness": "true",
    "cashandcashequivalentsatcarryingvalue": 4225521,
    "receivablesnetcurrent": 41246,
    "shortterminvestments": 6078031,
    "inventorynet": 224267,
    "prepaidexpensecurrent": 86919,
    "assetscurrent": 10655984,
    "equitymethodinvestments": 46456,
    "propertyplantandequipmentnet": 1062195,
    "depositsassetsnoncurrent": 15340,
    "assetsnoncurrent": 1123991,
    "assets": 11779975,
    "accountspayableandaccruedliabilitiescurrent": 493385,
    "liabilitiescurrent": 493385,
    "commonstockvalue": 56652957,
    "accumulatedsharebasedcompensation": 5064625,
    "retainedearningsaccumulateddeficit": -50430992,
    "stockholdersequity": -50430992,
    "liabilitiesandstockholdersequity": 11779975,
    "commonstocksharesissued": 5330715,
    "commonstocksharesoutstanding": 5330715,
    "revenuefromcontractwithcustomerincludingassessedtax": 211849,
    "revenues": 211849,
    "costofgoodsandservicessold": 133316,
    "othercostofoperatingrevenue": 312004,
    "researchanddevelopmentexpense": 2087402,
    "generalandadministrativeexpense": 2757377,
    "operatingexpenses": 5290099,
    "operatingincomeloss": -5078250,
    "foreigncurrencytransactiongainlossbeforetax": -35059,
    "investmentincomeinterest": 75160,
    "nonoperatingincomeexpense": 40101,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -5038149,
    "incometaxexpensebenefit": 800,
    "netincomeloss": -5038949,
    "earningspersharebasicanddiluted": -1.76,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 2869374,
    "depreciation": 188372,
    "sharebasedcompensation": 154313,
    "otherresearchanddevelopmentexpense": 12419,
    "incomelossfromequitymethodinvestments": -20239,
    "increasedecreaseinaccountsreceivable": 40004,
    "increasedecreaseininventories": 156153,
    "increasedecreaseinprepaidexpense": -36748,
    "increasedecreaseinaccountspayableandaccruedliabilities": 172451,
    "netcashprovidedbyusedinoperatingactivities": -4615505,
    "paymentstoacquirepropertyplantandequipment": 382810,
    "paymentstoacquireinvestments": 9083630,
    "proceedsfrommaturitiesprepaymentsandcallsofshortterminvestments": 5000000,
    "netcashprovidedbyusedininvestingactivities": -4466440,
    "proceedsfromissuanceofcommonstock": 4520319,
    "paymentsofstockissuancecosts": 398811,
    "proceedsfromwarrantexercises": 4650659,
    "netcashprovidedbyusedinfinancingactivities": 8772167,
    "effectofexchangerateoncashandcashequivalentscontinuingoperations": -35652,
    "cashandcashequivalentsperiodincreasedecrease": -345430,
    "cash": 3719041,
    "cashequivalentsatcarryingvalue": 506480,
    "incometaxespaidnet": 800,
    "shareissuancecostswithheldfromescrowproceeds": 972811,
    "issuanceofstockandwarrantsforservicesorclaims": 470912,
    "sharesoutstanding": 5330715,
    "stockissuedduringperiodvaluenewissues": 5493130,
    "stockissuedduringperiodsharesnewissues": 1388396,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 1371621,
    "stockissuedonexerciseofwarrantsvalue": 4650659,
    "stockissuedonexerciseofwarrantsshares": 2439449,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 154313,
    "workingcapital": 10200000,
    "propertyplantandequipmentusefullife": "P15Y",
    "othershortterminvestments": 6078031,
    "inventoryrawmaterialsandsupplies": 46670,
    "inventoryworkinprocess": 83297,
    "inventoryfinishedgoods": 94300,
    "propertyplantandequipmentdepreciablegross": 1782496,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1146566,
    "propertyplantandequipmentdepreciablenet": 635930,
    "constructioninprogressnondepreciable": 426265,
    "depreciationandamortization": 188000,
    "operatingleasesfutureminimumpaymentsduecurrent": 185000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 167000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 6000,
    "operatingleasesfutureminimumpaymentsdue": 358000,
    "lesseeoperatingleasetermofcontract": "P5Y",
    "lesseeoperatingleaserenewalterm": "P3Y",
    "operatingleasesrentexpensenet": 237000,
    "purchasecommitmentremainingminimumamountcommitted": 201000,
    "definedcontributionplanemployerdiscretionarycontributionamount": 75000,
    "definedcontributionplanemployersmatchingcontributionannualvestingpercentage": 1,
    "definedcontributionplanemployermatchingcontributionpercent": 0.03,
    "stockissuedduringperiodsharesperiodincreasedecrease": 3827845,
    "classofwarrantorrightoutstanding": 4093960,
    "numberofwarrantsgranted": 5665528,
    "numberofprefundedwarrantsgranted": 687076,
    "numberofwarrantsexercised": -1752373,
    "numberofprefundedwarrantsexercised": -687076,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 3.31,
    "weightedaverageexercisepriceofwarrantsgranted": 2.68,
    "weightedaverageexercisepriceofprefundedwarrantsgranted": 0.01,
    "weightedaverageexercisepriceofwarrantsexercised": 2.65,
    "weightedaverageexercisepriceofprefundedwarrantsexcercised": 0.01,
    "classofwarrantorrighstexpirydate": "2023-05-31",
    "fairvalueassumptionsrate": 1.55,
    "fairvalueassumptionexpectedterm": "P7Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 4215,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 29426,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 2266,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod1": 15373,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 25.42,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.88,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 84.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgrosstransactiontwo": 42.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 47778,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 120,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 130,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdaterangestart": "2018-11",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationdaterangeend": "2021-11",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardexpirationdate": "2020-11",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 228143,
    "weightedaveragecontractualliferemaining": "P28M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.67,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 72000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P28M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.98,
    "commonstockcapitalsharesreservedforfutureissuance": 142857,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -4306650,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -623835,
    "incomelossfromcontinuingoperationsbeforeincometaxesotherforeign": -107664,
    "deferredtaxassetsoperatinglosscarryforwards": 10646900,
    "deferredtaxassetsinprocessresearchanddevelopment": 1117100,
    "deferredtaxassetstaxdeferredexpense": 36400,
    "deferredtaxassetsshareissuancecosts": 981800,
    "deferredtaxliabilitiesusfederalbenefit": 666700,
    "deferredtaxliabilitiespropertyplantandequipment": 1800,
    "deferredtaxassetsvaluationallowance": 12113700,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.27,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -1360300,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 41700,
    "effectiveincometaxratereconciliationdeductionissuancecosts": 287300,
    "incometaxreconciliationforeignincometaxratedifferential": -33500,
    "incometaxreconciliationchangeinenactedtaxrate": 2906100,
    "incometaxreconciliationforeigncurrencydifferences": 9500,
    "incometaxreconciliationotheradjustments": -143100,
    "valuationallowancedeferredtaxassetchangeinamount": 40000,
    "currentstateandlocaltaxexpensebenefit": 800,
    "deferredfederalincometaxexpensebenefit": 2059300,
    "deferredforeignincometaxexpensebenefit": -446700,
    "deferredotherforeignincometaxexpensebenefit": -22600,
    "deferredstateandlocalincometaxexpensebenefit": -457700,
    "operatinglosscarryforwards": 8700000,
    "operatinglosscarryforwardsexpirationdate": "2038-12-31",
    "taxcreditcarryforwardamount": 580000,
    "financialinstrumentsownedusgovernmentandagencyobligationsatfairvalue": 6078031,
    "concentrationriskpercentage1": 0.87
  }
]